(RTTNews) - Acadia Pharmaceuticals Inc. (ACAD) said Wednesday that its Phase 3 COMPASS PWS study of carbetocin for the treatment of patients with hyperphagia or extreme hunger associated with ...

SAN DIEGO, September 24, 2025--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced top-line results from the Phase 3 COMPASS PWS trial evaluating the efficacy and safety of ...

Investing.com - Wells Fargo has reiterated an Overweight rating and $123.00 price target on Soleno Therapeutics Inc. (NASDAQ:SLNO) following a competitor’s clinical trial failure. The Wells Fargo ...

SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced top-line results from the Phase 3 COMPASS PWS trial evaluating the efficacy and safety of intranasal carbetocin ...

Investing.com -- Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) stock fell 13% Wednesday after the company announced that its Phase 3 COMPASS PWS trial evaluating intranasal carbetocin (ACP-101) for ...

The death of a tourist in Tasmania's Cradle Mountain National Park has prompted questions over the efficacy of safety measures in place. Premier Jeremy Rockliff shared his condolences for the family ...

Tonix Pharmaceuticals (TNXP) announced plans to progress its TNX-2900 program for the treatment of Prader-Willi syndrome into a Phase 2 clinical trial. TNX-2900 is a proprietary magnesium-potentiated ...

The Tennessee Volunteers took on the Mississippi State Bulldogs last Saturday, but things didn't go as planned. The Vols still won the game, but it took overtime to do so. Unfortunately for the ...

Wells Fargo believes Acadia Pharmaceuticals’ (ACAD) Phase 3 failure removes a near-term competitor to Soleno Therapeutics’ (SLNO) VYKAT XR. Wells thinks Soleno’s shares should trade up at least 20% on ...

Abstract: Accurate classification of port wine stains (PWS, vascular malformations present at birth), is critical for subsequent treatment planning. However, the current method of classifying PWS ...

Abstract: Extracting lesions with accurate boundaries from clinical images is crucial for the clinical diagnosis, progression monitoring, and efficacy evaluation of port wine stains (PWS). However, ...

Acadia Pharmaceuticals was testing the drug, an intranasal formulation of the oxytocin analogue carbetocin, for its potential to ease hyperphagia in the rare neurological condition. Acadia ...